학술논문
Weekly Paclitaxel, Carboplatin, and Cetuximab (PCC) as Treatment for Recurrent or Metastatic Head and Neck Squamous-cell Carcinoma (RM-HNSCC) that Progressed on Immune Checkpoint Inhibitors (ICI): A Retrospective Analysis
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e41-e42
Subject
Language
ISSN
0360-3016